Current Funding

The strength of our research team here in the Department of Ophthalmology is highlighted, in part, by their funding.

Funding by Researcher

John Ash, Ph.D.

  • NIH/NEI,  R01 EY016459-05  (Ash)
    Cytokine Regulation of Photoreceptor Gene Expression
    9/01/2010-8/31/2013
  • Foundation Fighting Blindness (Ash)
    “Using AAV-STAT3 and AAV-PIM1 vectors to induce broad-spectrum protection of photoreceptors and RPE”
    6/1/2013-5/31/2016

Sanford L. Boye, M.S.

  • “Retinoschisin Mouse Model Re-derivation and Efficacy Testing of AAV-RS1” (SL Boye)
    Funding Agency: AGTC
    Dates: 6/1/2014-5/31/2015
  •  “Evaluation of rAAV2tYF-CB-hRS1 Tox/BD Drug product for Transduction Efficiency and Rescue of ERG Responses in RS1 Knock-out Mice” (SL Boye and Hauswirth)
    Funding Agency: AGTC
    Dates: 3/4/2014-3/6/2015
  •  “Toxicology, Biodistribution and Efficacy Study of rAAV2tYF-CB-hRS1” (subproject- SL Boye)
    Funding Agency: Applied Genetics Technologies Corporation (AGTC)
    Dates: 12/10/13-12/09/14
  • “Gene Therapy for LCA1” (SE Boye)
    Funding Agency: Genzyme-Sanofi
    Dates: 3/1/2014-2/28/2016
  • “Vision Research Core” (P30EY021721)
    Funding Agency: NIH/National Eye Institute
    Role: Senior personnel, modules supervisor, (PI, Hauswirth)
    Dates: 8/1/2011-7/31/2016

Shannon E. Boye, Ph.D.

  • RO1EY024280 (SE Boye)
    “Developing Efficient AAV Vectors for Photoreceptor Targeting via the Vitreous”
    6/01/14-5/31/19
  • Genzyme/Sanofi (SE Boye)
    “Gene Therapy for LCA1”
    4/01/14-3/31/17
  • Foundation Fighting Blindness (SE Boye)
    Individual Investigator Research Award
    Targeting foveal cones using novel delivery methods and novel AAV serotypes
    6/01/12-6/01/15
  • Foundation Fighting Blindness (SE Boye)
    Individual Investigator Award
    “Dual AAV vector-mediated therapy for Myosin7A Usher syndrome (USH1B)”
    8/01/14-7/31/16
  • Foundation Fighting Blindness (Hauswirth and SE Boye)
    Wynn Gund TRAP (Translational Research Acceleration Program) Award
    Gene Therapy for LCA1
    10/1/10-9/30/15
  • AGTC Inc. Sponsored Research Agreement (SE Boye)
    10/1/14-9/30/16
  • AGTC Sponsored Research Agreement (Zolotukhin and SE Boye)
    10/1/14-9/30/17
  • Overstreet Endowment (Tuli)
    University of Florida Foundation
    Research in Age-Related Macular Degeneration
    6/1/2014-present

William W. Hauswirth, Ph.D.

  •  Grant Identifier: R24 EY022023 (Hauswirth)
    6/01/13-5/31/18
    Sponsor: NEI
    Title of Grant: rAAV-CNGB3 Gene Therapy for Achromatopsia: Translational Research Studies
  • Grant Identifier: P30-EY021721 (Hauswirth)
    8/01/11-7/31/16
    Sponsor: NEI
    Title of Grant: Vision Research Center
  • Grant Identifier: NA (Hauswirth)
    1/01/13-12/31/16
    Sponsor: Macular Vision Research Foundation
    Title of Grant: Gene Therapy for Blue Cone Monochromacy (BCM)
  • Grant Identifier: NA (Hauswirth)
    7/1/13-6/30/16
    Sponsor: Elden Family Foundation
    Title of Grant: Gene Therapy for Ush3A
  • Grant Identifier: 2011445 (Banin)
    10/01/12-9/30/16
    Sponsor: US Israel Binational Science Foundation
    Title of Grant: Gene Therapy Using Novel Viral Vectors in the CNGA3 Sheep Model of Achromatopsia
  • Grant Identifier: TA-GT-0911-0559-AGTC-WG (Washer)
    10/01/12-9/30/16
    Sponsor: Foundation Fighting Blindness
    Title of Grant: AAV-based Gene Therapy for X-linked Retinoschisis
  • Grant Identifier: R24 EY022012 (Beltran)
    3/01/12-2/28/16
    Sponsor: NEI
    Title of Grant: Translational Gene Therapy for Rhodopsin Autosomal Dominant Retinitis Pigmentosa
  • Grant Identifier: R01 EY017549 (Aguirre)
    9/30/06-7/31/15
    Sponsor: NEI
    Title of Grant: Translational Research for Retinal Degeneration Therapies
  • Grant Identifier: C-GT-071-0536-UFL04 (Weleber)
    7/01/11-6/30/16
    Sponsor: Foundation Fighting Blindness
    Title of Grant: OHSU Research Center for the Study of Retinal Degenerations
  •  Grant Identifier: U10-EY017280 (Jacobson)
    9/30/06-7/31/15
    Sponsor: NEI
    Title of Grant: Clinical Trials of Gene Therapy for Leber Congenital Amaurosis Type 2
  •  Grant Identifier: C-GT-0812-0590-UFL03 (Jacobson)
    8/1/12-7/31/17
    Sponsor: Foundation Fighting Blindness
    Title of Grant: FFB Center at the Scheie Eye Center
  •  Grant Identifier: FFB TA-GT-0611-0526-UF (Lewin)
    6/30/14-6/29/17
    Sponsor: Foundation Fighting Blindness
    Title of Grant: RNA Replacement Therapy for ADRP
  •  Grant Identifier: R01 EY012978 (Nirenberg)
    2/1/13-1/31/17
    Sponsor: NEI
    Title of Grant: Population Coding in the Retina

Qiuhong Li, Ph.D.

  • NIH RO1 (Li)
    Renin Angiotensin System in Pathogenesis of Diabetic Retinopathy
    1/1/2012-12/31/2015
  • NIH RO1 (Grant/Raizada)
    Vascular Reparative Mechanism by ACE2/Ang-(1-7) in Diabetes
    7/1/2011 – 6/30/2016

Daniel M. Lipinski, D.Phil.

  • Juvenile Diabetes Research Foundation (JDRF) Innovative Award (1-PNF-2014-120-A-N)
    Validation of a novel AAV vector for targeted gene therapy to prevent vascular complications of diabetic retinopathy (PI: Lipinski)
    5/01/2014-10/31/2015

Jijing Pang, MD, Ph.D.

  • 2014 UF Faculty Enhancement Opportunity Award
  • Macula Vision Research Foundation (Hauswirth and Pang)
    “Vitreal delivery of novel AAV vectors for blue cone monochomacy (BCM)”
    01/01/14 – 12/31/16
  • R21EY023543 (Pang)
    “Vitreal delivery of novel AAV vectors for CNGA3 achromatopsia cone gene therapy”
    08/01/2013 – 07/31/2015
  • UF and WMU agreement (Pang) to design, produce and deliver the AAV vectors to WMC
    07/01/2013 – 12/31/2017
  • International collaboration project by The Ministry of Science and Technology of China 2010DFB33430 (China PI: Fangtian Dong, US PI: Jijing Pang)
    “Genetic diagnosis and gene therapy of inherited retinal degeneration in China”
    01/01/2011 to 12/31/15

Clay Smith, Ph.D.

  • NIH National Eye Institute/ R01 EY014864-06 Smith (PI)
    Arrestin Migration in Photoreceptors: Mechanism/Function”
    08/01/11 – 6/30/15
  • NIH National Eye Institute (Smith)
    “Training in Vision Sciences”
    01/01/10-12/31/14
  • Overstreet Foundation (Tuli)
    University of Florida Foundation Research in Age-Related Macular Degeneration
    10/01/11-present
  • Shaler-Richardson Professorship (Smith)
    College of Medicine, Univ. of Florida
    4/1/09-present

Sonal Tuli, M.D.

  • NIH RO1 – EY 05587-25  (Co-I)
    Regulation of Stromal Wound by Growth Factors
  • CTSI Training Award (mentor)
    8/2014-8/2015